Mucus glycoprotein disulfide bonds

Mucus glycoprotein disulfide bonds are critical structural elements that maintain the three-dimensional gel matrix of airway secretions. These covalent cross-links primarily occur between the cysteine-rich domains (D-domains) of large, secreted mucins, such as MUC5AC and MUC5B, allowing them to polymerize into high-molecular-weight networks (PubMed: 25637151). In healthy airways, this gel provides a protective barrier and facilitates mucociliary clearance; however, in diseases like cystic fibrosis and COPD, hypersecretion and increased cross-linking lead to pathologically thick mucus that obstructs the airways (NIH: PMC8003733). Thiol-based mucolytic agents, such as N-acetylcysteine, target these disulfide bonds by acting as reducing agents that break the bridges into free sulfhydryl groups (StatPearls: NBK537183). This chemical reduction results in the depolymerization of the mucin network, significantly decreasing the viscosity and elasticity of the mucus. By thinning the secretions, these drugs help restore airway patency and improve the clearance of obstructive mucus plugs in patients with chronic respiratory conditions.

Other names

Mucin disulfide bridgesMucus glycoprotein cross-linksInter-molecular disulfide bonds in mucinsThiol-reducible mucin polymers

Reduction of inter-molecular disulfide bridges between mucin monomers to free sulfhydryl groups, leading to depolymerization and reduced mucus viscosity.